Hyperlipidaemic pancreatitis
Conditions
Interventions
Hyperlipidemic pancreatitis group:None
Healthy group:None
Sponsors
Zhongshan Hospital, Xiamen University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1: Experimental group:Age 18-65 years; patients with confirmed diagnosis of hyperlipidemic pancreatitis with onset ? 1; provided written informed consent and willing to comply with the requirements of the study protocol. 2: Control group:Matched for age and gender in the hyperlipidemic pancreatitis group; BMI 18.5-23.95 kg/m2; provided written informed consent and willingness to comply with the requirements of the study protocol.
Exclusion criteria
Exclusion criteria: 1: Experimental group: patients with incomplete data; patients with pancreatic cancer; those with concurrent chronic or serious diseases of other systems, such as severe liver and kidney disease, chronic lung disease, acute pulmonary embolism, lower extremity venous thrombosis, chronic cardiac insufficiency; use of antibiotics in the month prior to enrollment; recent history of gastrointestinal tract, history of acute gastroenteritis in the last week; use of immunosuppressant drugs, NSAIDs, pro gastrointestinal stimulants, proton pump inhibitors, and probiotics; those who have taken traditional Chinese medicines and proprietary Chinese medicines in the past 6 months; those who suffer from digestive disorders such as dysentery, inflammatory bowel disease, irritable bowel syndrome, and intestinal tumors; those who are participating in other research studies at the time of enrollment; those who have cognitive dysfunction, speech dysfunction, or dysfunction; those who have a history of psychiatric disorde 2: Control group: patients with incomplete data; those with concomitant chronic or serious diseases of other systems, such as severe liver and kidney disease, chronic lung disease, acute pulmonary embolism, lower extremity venous thrombosis, chronic cardiac insufficiency; use of antibiotics in the month prior to enrollment; recent history of gastrointestinal tract, history of acute gastroenteritis in the last week; immunosuppressant agents, non-steroidal anti-inflammatory drugs, pro-gastrointestinal dynamics drugs were used in the month prior to the collection of samples, proton pump inhibitors and probiotics; those who took traditional Chinese medicines and proprietary Chinese medicines within 6 months, etc.; patients suffering from digestive diseases such as dysentery, inflammatory bowel disease, irritable bowel syndrome, intestinal tumors, etc.; those who were participating in other research studies at the time of enrollment; those who had cognitive dysfunction, speech dysfunction, or dysfunction; those who had history of psychiatric disorders; pregnant/nursing females; those who had any intestinal resections; those who had been heavy alcohol drinkers (average daily alcohol consumption of ? 50g (pure alcohol) per day on average, with a history of alcohol consumption >5 years; Western diet, ketogenic diet, vegetarian diet were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| triglyceride;Total cholesterol;Low-density lipoprotein; | — |
Countries
China
Contacts
Public ContactWang Lin
Zhongshan Hospital, Xiamen University
Outcome results
None listed